Clinical studies of p53 in treatment and benefit of breast cancer patients
- PMID: 10732788
- DOI: 10.1677/erc.0.0060051
Clinical studies of p53 in treatment and benefit of breast cancer patients
Abstract
This article describes p53 as a prognostic and predictive factor, together with some information on how best to determine the p53 status. By December 1998, 13,000 articles on p53 were identified on Pub Med, the National Library of Medicine. Within one week a further 62 articles were recorded making it difficult to give the complete p53 story. This review article will focus on discussing p53 in relation to its predictive potential. So far, no firm conclusions can be made based on the articles studied. This may be, in part, because many studies have used less than optimal techniques for determination of the p53 status, together with the fact that the studies lacked power to detect a potential difference in outcome from specific therapy in relation to p53 status.
Similar articles
-
Expression of ras p21, p53 and c-erbB-2 in advanced breast cancer and response to first line hormonal therapy.Br J Cancer. 1995 Nov;72(5):1259-66. doi: 10.1038/bjc.1995.497. Br J Cancer. 1995. PMID: 7577479 Free PMC article.
-
Enhanced prediction of breast cancer prognosis by evaluating expression of p53 and prostate-specific antigen in combination.Br J Cancer. 1999 Oct;81(3):490-5. doi: 10.1038/sj.bjc.6690720. Br J Cancer. 1999. PMID: 10507775 Free PMC article.
-
[Therapeutic targeting in breast cancer].Ann Pathol. 2009 Nov;29 Spec No 1:S71-3. doi: 10.1016/j.annpat.2009.07.047. Epub 2009 Oct 21. Ann Pathol. 2009. PMID: 19887259 Review. French. No abstract available.
-
Predicting response to adjuvant and radiation therapy in patients with early stage breast carcinoma.Cancer. 1998 Mar 1;82(5):874-7. doi: 10.1002/(sici)1097-0142(19980301)82:5<874::aid-cncr11>3.0.co;2-y. Cancer. 1998. PMID: 9486576
-
p53 in breast cancer subtypes and new insights into response to chemotherapy.Breast. 2013 Aug;22 Suppl 2:S27-9. doi: 10.1016/j.breast.2013.07.005. Breast. 2013. PMID: 24074787 Review.
Cited by
-
Blestriarene C exerts an inhibitory effect on triple-negative breast cancer through multiple signaling pathways.Front Pharmacol. 2024 Oct 22;15:1434812. doi: 10.3389/fphar.2024.1434812. eCollection 2024. Front Pharmacol. 2024. PMID: 39502536 Free PMC article.
-
Invasive breast cancer: correlation of dynamic MR features with prognostic factors.Eur Radiol. 2003 Nov;13(11):2425-35. doi: 10.1007/s00330-003-2000-y. Epub 2003 Jul 26. Eur Radiol. 2003. PMID: 12898176
-
Breast cancer response to neoadjuvant chemotherapy: predictive markers and relation with outcome.Br J Cancer. 2003 Feb 10;88(3):406-12. doi: 10.1038/sj.bjc.6600749. Br J Cancer. 2003. PMID: 12569384 Free PMC article.
-
Studies of apoptosis in breast cancer.BMJ. 2001 Jun 23;322(7301):1528-32. doi: 10.1136/bmj.322.7301.1528. BMJ. 2001. PMID: 11420276 Free PMC article. Review. No abstract available.
-
The prognostic value of the AgNOR parameter in human breast cancer depends on the pRb and p53 status.J Clin Pathol. 2004 Jul;57(7):755-61. doi: 10.1136/jcp.2003.015917. J Clin Pathol. 2004. PMID: 15220371 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous